MedTrace Logo

Sinopsys Lacrimal Stent Indicated for Sinus Irrigation

NCT02297243 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2016-02-12

No results posted yet for this study

Summary

The purpose of this study is to collect preliminary clinical data related to the safety and performance of the Sinopsys Lacrimal Stent.

Conditions

  • Ethmoid Sinusitis

Interventions

DEVICE

Sinopsys Lacrimal Stent

The Sinopsys Lacrimal Stent is indicated for use to create a transcaruncular ethmoid sinus access.

Sponsors & Collaborators

  • Sinopsys Surgical

    lead INDUSTRY

Principal Investigators

  • Teena Augustino · Sinopsys Surgical Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02297243 on ClinicalTrials.gov